Imagen de Portada

Engineered cell versus modified exosomes in cancer therapy

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Rajib Dhar, Arikketh Devi
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Clinical and Translational Discovery
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Milk exosomes: Harnessing nature's duality for cancer therapy
por: Asmit Das, et al.
Publicado: (2024)

Tumor and cancer stem cells‐derived exosomes interplay: A secret of cancer complications
por: Swarup Sonar, et al.
Publicado: (2024)

Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
por: Swastika Maitra, et al.
Publicado: (2024)

Clinical signature of exosomal tetraspanin proteins in cancer
por: Asmit Das, et al.
Publicado: (2024)

The prospective trajectory of exosomes‐based cancer nanomedicine
por: Divya Mirgh, et al.
Publicado: (2024)

Clinical trial status of exosomes‐based cancer theranostics
por: Swarup Sonar
Publicado: (2024)

Signature of click chemistry in exosome modification for cancer therapeutic
por: Nobendu Mukerjee, et al.
Publicado: (2024)

Plant exosomes: A natural medicine for oral cancer
por: Sidhanti Nyahatkar, et al.
Publicado: (2024)

Modified plant‐derived exosomes: Precision medicine in cancer treatment
por: Swastika Maitra, et al.
Publicado: (2024)

Sweat exosomes: A new cutting edge nanomedicine in cancer treatment
por: Bikram Dhara, et al.
Publicado: (2024)

Plant‐derived exosomes: A Green Nanomedicine for Cancer
por: Swarup Sonar, et al.
Publicado: (2024)

scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
por: Fansen Ji, et al.
Publicado: (2025)

Effects of microRNA on the growth and targeted therapy response on lung cancer
por: Mengchen Zhu, et al.
Publicado: (2024)

Liquid biopsy—A biomarker‐based revolutionising technique in cancer therapy
por: Subham Sarkar, et al.
Publicado: (2024)

Mesenchymal stem cell therapy for ulcerative colitis: Opportunities and challenges in precision medicine
por: Peng‐Fei Wang, et al.
Publicado: (2025)

Bacterial surface derived extracellular vesicles: A ground‐breaking approach in cancer therapy
por: Asmit Das, et al.
Publicado: (2024)

Sculpting nursing resilience: Transforming lives, nurturing ethics in chimeric antigen receptor T‐cell therapy
por: Pranay Bende
Publicado: (2024)

Translational values of tissue‐resident memory T cells in chronic inflammation and cancer
por: Wanxin Duan, et al.
Publicado: (2025)

Host–microbiota interaction during cancer progression from bulk to single‐cell level
por: Yong‐Jing Ma, et al.
Publicado: (2024)

Single‐cell sequencing for cancer precision medicine: From mechanism discovery to diagnosis and therapeutics
por: Yue Zhao, et al.
Publicado: (2026)

Anti‐PF4 antibody inhibit proliferation of lung cancer cells without TP53 mutation by inducing apoptosis and cell cycle arrest
por: Mengjia Qian, et al.
Publicado: (2025)

Gastric cancer detection based on cell‐free DNA in blood: A systematic review and meta‐analysis
por: Mona Wang, et al.
Publicado: (2024)

Inflammatory‐associated myeloid dendritic cells reveals associations between chronic lung diseases and lung cancer
por: Zhiyu Chen, et al.
Publicado: (2024)

Challenges and advances of immune checkpoint therapy
por: Lingyu Li, et al.
Publicado: (2024)

Tumour hepcidin levels as a biomarker for predicting response to immune checkpoint inhibition in advanced non‐small cell lung cancer
por: Yuichiro Suzukawa, et al.
Publicado: (2026)

Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
por: Xinni Chen, et al.
Publicado: (2026)

Targeting mutated KRAS in the first‐line therapy
por: Hideaki Ijichi
Publicado: (2024)

Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies
por: Yushan Huang, et al.
Publicado: (2026)

EccDNA, STING activation, and their potential roles in DLBCL prognosis and therapy
por: Xi‐Bo Hu, et al.
Publicado: (2024)

Single‐cell and spatial alterations of neural cells and circuits in clinical and translational medicine
por: William Wang, et al.
Publicado: (2024)

Clinical and translational mode of single‐cell measurements: An artificial intelligent single cell
por: Xiangdong Wang, et al.
Publicado: (2024)

Roles of telocytes dominated cell–cell communication in fibroproliferative acute respiratory distress syndrome
por: Yonghua Zheng, et al.
Publicado: (2024)

CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
por: Dongchun Xie, et al.
Publicado: (2024)

Spatial omics accelerate the study of cancer‐associated fibroblasts in non‐small lung cancer
por: Haozhen Liu, et al.
Publicado: (2024)

Exploring new frontiers in lung cancer treatment: The role of cancer‐associated fibroblasts (CAFs) and EGFR‐TKI resistance
por: Jiaqi Liang, et al.
Publicado: (2025)

The role of T cells in sepsis of distinct infectious aetiologies
por: Xuanqi Liu, et al.
Publicado: (2026)

Significance of stereologically spatiotemporal cells in molecular medicine
por: Xuanqi Liu, et al.
Publicado: (2025)

Investigating the biological effects of socioeconomic adversity in cancer
por: David Füller
Publicado: (2024)

Nanomedicine: a frontier of the breast cancer treatment
por: Swarup Sonar, et al.
Publicado: (2024)

The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy
por: Jing Zhao, et al.
Publicado: (2025)